Xeris Biopharma (0A8E.LSE) Q4 2023 Earnings

Mar 6Confirmed
Q4 2023
-0.1
-0.1
-0.09
-0.09

Details

Expected EPS
-0.085491
Actual EPS
-0.1
Surprise EPS
-0.01
Surprise Percent
-16.97%

Description

⁨Xeris Biopharma⁩ (⁦0A8E.LSE⁩) has reported earnings of ⁦-0.1⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts